Cargando…

Ki67 in Breast Cancer Assay: An Ad Hoc Testing Recommendation from the Canadian Association of Pathologists Task Force

Ki67, a marker of cellular proliferation, is commonly assessed in surgical pathology laboratories. In breast cancer, Ki67 is an established prognostic factor with higher levels associated with worse long-term survival. However, Ki67 IHC is considered of limited clinical use in breast cancer manageme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Faragalla, Hala, Plotkin, Anna, Barnes, Penny, Lu, Fang-I, Kos, Zuzana, Mulligan, Anna Marie, Bane, Anita, Nofech Mozes, Sharon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Guidelines
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047249/ https://www.ncbi.nlm.nih.gov/pubmed/36975446 http://dx.doi.org/10.3390/curroncol30030233

Ejemplares similares

Guidelines from the Canadian Association of Pathologists for establishing a telepathology service for anatomic pathology using whole-slide imaging
por: Bernard, Chantal, et al.
Publicado: (2014)

piNET–An Automated Proliferation Index Calculator Framework for Ki67 Breast Cancer Images
por: Geread, Rokshana Stephny, et al.
Publicado: (2020)

HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ
por: Rakovitch, E, et al.
Publicado: (2012)

MLH1 Methylation Testing as an Integral Component of Universal Endometrial Cancer Screening—A Critical Appraisal
por: Plotkin, Anna, et al.
Publicado: (2023)

Guidance for Remote Reporting of Digital Pathology Slides During Periods of Exceptional Service Pressure: An Emergency Response from the UK Royal College of Pathologists
por: Williams, Bethany Jill, et al.
Publicado: (2020)

Thrombosis in multiple myeloma: risk stratification, antithrombotic prophylaxis, and management of acute events. A consensus-based position paper from an ad hoc expert panel
por: De Stefano, Valerio, et al.
Publicado: (2022)

Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration
por: Leung, Samuel C Y, et al.
Publicado: (2016)

Credentialing for endoscopic ultrasound: A proposal for Canadian guidelines
por: Arya, Naveen, et al.
Publicado: (2016)

Canadian Consensus Recommendations on the Management of MET-Altered NSCLC
por: Cheema, Parneet K., et al.
Publicado: (2021)

Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Adults †
por: Bebb, D. Gwyn, et al.
Publicado: (2021)

Management of Pyrexia Associated with the Combination of Dabrafenib and Trametinib: Canadian Consensus Statements
por: Thawer, Alia, et al.
Publicado: (2021)

Canadian Association of Radiologists Guidance on Contrast-Associated Acute Kidney Injury
por: Macdonald, D. Blair, et al.
Publicado: (2022)

Canadian Society of Transplantation and Canadian Society of Nephrology Commentary on the 2017 KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors
por: Lam, Ngan N., et al.
Publicado: (2020)

SARS-CoV-2 routes of transmission and recommendations for preventing acquisition: joint British Infection Association (BIA), Healthcare Infection Society (HIS), Infection Prevention Society (IPS) and Royal College of Pathologists (RCPath) guidance
por: Bak, A., et al.
Publicado: (2021)

Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in Pediatric Patients
por: Perreault, Sébastien, et al.
Publicado: (2021)

Canadian guideline for the clinical management of high-risk drinking and alcohol use disorder
por: Wood, Evan, et al.
Publicado: (2023)

Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer
por: Melosky, Barbara L., et al.
Publicado: (2023)

Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC
por: Cheema, Parneet K., et al.
Publicado: (2023)

HER2-LOW BREAST CANCER BRAIN METASTASES: INCIDENCE AND TREATMENT IMPLICATIONS
por: Chehade, Rania, et al.
Publicado: (2023)

Canadian Guideline on the Management of a Positive Human Papillomavirus Test and Guidance for Specific Populations
por: Zigras, Tiffany, et al.
Publicado: (2023)

Current Role of Immunotherapy in Gastric, Esophageal and Gastro-Esophageal Junction Cancers—A Report from the Western Canadian Gastrointestinal Cancer Consensus Conference
por: Mulder, Karen, et al.
Publicado: (2022)

2023 Canadian Colposcopy Guideline: A Risk-Based Approach to Management and Surveillance of Cervical Dysplasia
por: Willows, Karla, et al.
Publicado: (2023)

The Use of Optical Coherence Tomography for Gross Examination and Sampling of Fixed Breast Specimens: A Pilot Study
por: Faragalla, Hala, et al.
Publicado: (2022)

COVID-19 vaccine testing & administration guidance for allergists/immunologists from the Canadian Society of Allergy and Clinical Immunology (CSACI)
por: Vander Leek, Timothy K., et al.
Publicado: (2021)

Core elements of participant consent documents for Canadian human genomics research and the National Human Genome Library: guidance for policy
por: Longstaff, Holly, et al.
Publicado: (2022)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

Choosing Wisely: The Canadian Society of Nephrology’s List of 5 Items Physicians and Patients Should Question
por: Chan, Emilie, et al.
Publicado: (2017)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

A Guide to Implementing Immune Checkpoint Inhibitors within a Cancer Program: Experience from a Large Canadian Community Centre
por: Cheema, Parneet K., et al.
Publicado: (2022)

Canadian Cardiovascular Harmonized National Guideline Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2022 update
por: Jain, Rahul, et al.
Publicado: (2022)

Protein bomarkers Ki67, HOXC10 and HOXC11 for the prediction of response to endocrine treatment in breast cancer
por: Soon, YH, et al.
Publicado: (2015)

Added value of CE-CT radiomics to predict high Ki-67 expression in hepatocellular carcinoma
por: Zhao, Yu-meng, et al.
Publicado: (2023)

Updated Canadian Expert Consensus on Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease
por: Soroka, Steven, et al.
Publicado: (2018)

A proposal for the ideal algorithm for the diagnosis, staging, and treatment of pancreas masses suspicious for pancreatic adenocarcinoma: Results of a working group of the Canadian Society for Endoscopic Ultrasound
por: Arya, Naveen, et al.
Publicado: (2020)

The COVID-19 pandemic and eating disorders in children, adolescents, and emerging adults: virtual care recommendations from the Canadian consensus panel during COVID-19 and beyond
por: Couturier, Jennifer, et al.
Publicado: (2021)

Corrigendum: To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

Gadolinium-Based Contrast Agents in Kidney Disease: A Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists
por: Schieda, Nicola, et al.
Publicado: (2018)

The intrinsically disorderly story of Ki-67
por: Remnant, Lucy, et al.
Publicado: (2021)

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
por: Fasanella, S, et al.
Publicado: (2011)

Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
por: Nielsen, Torsten O, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gh1oi25e3ntfn55c7ti5edikhe